132 related articles for article (PubMed ID: 22139024)
1. TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis.
Lv ZD; Wang HB; Li FN; Wu L; Liu C; Nie G; Kong B; Qu HL; Li JG
Int J Mol Med; 2012 Mar; 29(3):373-9. PubMed ID: 22139024
[TBL] [Abstract][Full Text] [Related]
2. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.
Lv ZD; Na D; Liu FN; Du ZM; Sun Z; Li Z; Ma XY; Wang ZN; Xu HM
J Exp Clin Cancer Res; 2010 Oct; 29(1):139. PubMed ID: 21034459
[TBL] [Abstract][Full Text] [Related]
3. Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro.
Lv ZD; Na D; Ma XY; Zhao C; Zhao WJ; Xu HM
Int J Mol Med; 2011 Feb; 27(2):187-93. PubMed ID: 21152863
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic effect of TGF-β1 on mesothelial cells via apoptosis in early peritoneal carcinomatosis.
Lv ZD; Yang ZC; Wang HB; Li JG; Kong B; Wang XG; Liu XY; Niu ZH; Wang Y; Nie G
Oncol Rep; 2012 Jun; 27(6):1753-8. PubMed ID: 22447164
[TBL] [Abstract][Full Text] [Related]
5. [Effect of peritoneal fibrosis induced by transforming growth factor-beta 1 on the adhesion of gastric cancer cell].
Lü ZD; Xu HM; Wang HB; Kong B; Li JG; Li FN; Song YM
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1698-701. PubMed ID: 22944162
[TBL] [Abstract][Full Text] [Related]
6. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
Lv ZD; Zhao WJ; Jin LY; Wang WJ; Dong Q; Li N; Xu HM; Wang HB
Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.
Duan WJ; Yu X; Huang XR; Yu JW; Lan HY
Am J Pathol; 2014 Aug; 184(8):2275-84. PubMed ID: 24925688
[TBL] [Abstract][Full Text] [Related]
9. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
Lv ZD; Wang HB; Dong Q; Kong B; Li JG; Yang ZC; Qu HL; Cao WH; Xu HM
Mol Cell Biochem; 2013 May; 377(1-2):177-85. PubMed ID: 23392771
[TBL] [Abstract][Full Text] [Related]
10. Osthole inhibits the expressions of collagen I and III through Smad signaling pathway after treatment with TGF-β1 in mouse cardiac fibroblasts.
Liu JC; Wang F; Xie ML; Cheng ZQ; Qin Q; Chen L; Chen R
Int J Cardiol; 2017 Feb; 228():388-393. PubMed ID: 27870967
[TBL] [Abstract][Full Text] [Related]
11. [Role of transforming growth factor-β1 in epithelial-mesenchymal transition of mesothelial cells and its effect on peritoneal metastasis of gastric cancer].
Lyu Z; Kong B; Liu X; Li F; Wang H; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jan; 18(1):54-7. PubMed ID: 25656033
[TBL] [Abstract][Full Text] [Related]
12. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
Na D; Lv ZD; Liu FN; Xu Y; Jiang CG; Sun Z; Miao ZF; Li F; Xu HM
Int J Mol Med; 2010 Sep; 26(3):325-32. PubMed ID: 20664947
[TBL] [Abstract][Full Text] [Related]
14. Smad7 inhibits TGF-β1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells.
Wang X; Li X; Ye L; Chen W; Yu X
Int Urol Nephrol; 2013 Jun; 45(3):899-907. PubMed ID: 23242502
[TBL] [Abstract][Full Text] [Related]
15. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F
Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608
[TBL] [Abstract][Full Text] [Related]
16. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells.
Kolosova I; Nethery D; Kern JA
J Cell Physiol; 2011 May; 226(5):1248-54. PubMed ID: 20945383
[TBL] [Abstract][Full Text] [Related]
17. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
18. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
[TBL] [Abstract][Full Text] [Related]
19. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.
Miao ZF; Zhao TT; Wang ZN; Miao F; Xu YY; Mao XY; Gao J; Wu JH; Liu XY; You Y; Xu H; Xu HM
Tumour Biol; 2014 Apr; 35(4):3575-83. PubMed ID: 24347485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
